Bright Minds Biosciences Inc. Share Price
Equities
DRUG
CA10919W4056
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 CAD | -12.24% | -21.82% | -39.15% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 8.11M 11.18M 650M |
---|---|---|---|---|---|
Net income 2022 | -15M -20.67M -1.2B | Net income 2023 | -7M -9.65M -561M | EV / Sales 2022 | - |
Net cash position 2022 | 11.49M 15.83M 921M | Net cash position 2023 | 6.67M 9.2M 535M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.4
x | P/E ratio 2023 |
-1.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.85% |
1 day | -12.24% | ||
1 week | -21.82% | ||
Current month | -12.84% | ||
1 month | -21.82% | ||
3 months | -54.74% | ||
6 months | -30.27% | ||
Current year | -39.15% |
Managers | Title | Age | Since |
---|---|---|---|
Ian McDonald
FOU | Founder | 37 | 30/05/19 |
Ryan Cheung
DFI | Director of Finance/CFO | 45 | 28/05/20 |
Jan Pedersen
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/03/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian McDonald
FOU | Founder | 37 | 30/05/19 |
David Weiner
BRD | Director/Board Member | 59 | 16/02/23 |
Jeremy Fryzuk
BRD | Director/Board Member | 39 | 28/09/20 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 1.3 | -11.56% | 23,500 |
26/04/24 | 1.47 | -10.91% | 100 |
Delayed Quote Canadian Securities Exchange, April 30, 2024 at 08:11 pm
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.15% | 4.81M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- DRUG Stock